Conformis, Inc.
- Jurisdiction
United States - ISIN
US20717E1010 (CFMS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
2
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. Read full profile
Fundamentals
- Net revenue
€48.67M - Gross margin
33.2% - EBIT
-€34.56M - EBIT margin
-71.0% - Net income
-€35.40M - Net margin
-72.7%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Earnings Calls
Latest earnings call: May 8, 2023 (Q1 2023)